Sonora Investment Management’s Perspective Therapeutics CATX Stock Holding History

Sonora Investment Management’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1K	Buy	+200	New	+$1.36K	﹤0.01%	1032
2017 Q3	–	Sell	-500	Closed	-$3.13K	–	1191
2017 Q2	$3.13K	Hold	500	–	–	﹤0.01%	873
2017 Q1	$2.95K	Hold	500	–	–	﹤0.01%	833
2016 Q4	$2.9K	Hold	500	–	–	﹤0.01%	750
2016 Q3	$3.6K	Hold	500	–	–	﹤0.01%	716
2016 Q2	$4.35K	Hold	500	–	–	﹤0.01%	711
2016 Q1	$5.7K	Hold	500	–	–	﹤0.01%	711
2015 Q4	$5K	Buy	+500	New	+$6.23K	﹤0.01%	625

Other funds holding CATX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HPWM

Highland Private Wealth Management Bellevue, Washington $620M AUM 18.88% 1-Year Est. Return

Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Sonora Investment Management's CATX Position: Q3 2021 in Review

Sonora Investment Management opened a new position in Perspective Therapeutics (CATX) in Q3 2021: 200 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1032 among its holdings. This is a return to the name: Sonora Investment Management previously reported a position in CATX as recently as Q2 2017.

Sonora Investment Management first reported a position in CATX in Q4 2015 and has held it in 8 quarters since. The position peaked at $5.7K in Q1 2016. 43 funds tracked by Wall St. Rank hold CATX as of Q3 2021.

Sonora Investment Management held 200 shares of Perspective Therapeutics worth $1K as of Q3 2021.
Perspective Therapeutics was a new Sonora Investment Management position in Q3 2021.
Perspective Therapeutics made up ﹤0.01% of Sonora Investment Management's portfolio in Q3 2021, its #1032 holding.
Sonora Investment Management first reported a position in Perspective Therapeutics in Q4 2015 and has held it in 8 quarters since.
Sonora Investment Management's Perspective Therapeutics position peaked at $5.7K in Q1 2016.
43 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.